Bob Bollinger's profile picture

Bob Bollinger

Medical Director and Company Board Member at Scene Health

Bob Bollinger's work experience began in 1992 when they became a Professor at Johns Hopkins School of Medicine. In 2013, they joined emocha Mobile Health Inc as the Medical Director and Company Board Member. Bob also served as the Founding Inventor of emocha Mobile Health Inc. In the same year, they founded and became the Director of the miLAB Program at The Johns Hopkins University. The miLAB Program focused on developing low-cost, point-of-care diagnostics in collaboration with imec in Belgium and led to the establishment of a joint start-up company called miDiagnostics. During their time with the miLAB Program, Bob Bollinger spearheaded the development of four point-of-care platforms for identifying and quantifying cells, nucleic acids, proteins, and small molecules. Bob concluded their role at the miLAB Program in October 2018.

Bob Bollinger has an extensive education history. Bob started their education at Haverford College in 1975 and completed their Bachelor's Degree in Philosophy and Chemistry in 1979. Afterward, Bob enrolled at the Geisel School of Medicine at Dartmouth, where they pursued and successfully obtained a Doctor of Medicine (M.D.) degree in 1984. Following this, they furthered their education at the Johns Hopkins Bloomberg School of Public Health, specializing in International Public Health/International Health. In 1986, they completed their studies and earned a Master of Public Health (M.P.H.) degree. Additionally, Bob also pursued another Master of Public Health degree at the Johns Hopkins Bloomberg School of Public Health. The exact duration of this program is unspecified. Overall, Bob's education journey includes a Bachelor's Degree, a Doctor of Medicine degree, and two Master of Public Health degrees.

Location

Towson, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


S

Scene Health

Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Our 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivational content, we bringhealthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Our mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. We make it fun for patients to stay on top of their medications, help them address any medication challenges, and empower them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases.


Employees

51-200

Links